Finger, E., Berry, S., Cummings, J., Coleman, K., Hsiung, R., Feldman, H. H., & Boxer, A. (2018). Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: A phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY). Alzheimers Res Ther.
Citação norma ChicagoFinger, Elizabeth, Scott Berry, Jeffrey Cummings, Kristy Coleman, Robin Hsiung, Howard H. Feldman, and Adam Boxer. "Adaptive Crossover Designs for Assessment of Symptomatic Treatments Targeting Behaviour in Neurodegenerative Disease: A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia (FOXY)." Alzheimers Res Ther 2018.
MLA citiranjeFinger, Elizabeth, et al. "Adaptive Crossover Designs for Assessment of Symptomatic Treatments Targeting Behaviour in Neurodegenerative Disease: A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia (FOXY)." Alzheimers Res Ther 2018.